marketcaparena
Search

    ASBP

    Aspire Biopharma Holdings, Inc.

    Company overview

    Market capitalization
    $11.92M
    Employees
    0
    Latest publication
    2026-09-29
    About Aspire Biopharma Holdings, Inc.

    Aspire Biopharma Holdings, Inc., an early-stage biopharmaceutical company, develops and markets disruptive technology for novel sublingual delivery mechanisms in the United States. It offers sublingual aspirin product that is a soluble, PH neutral, and fast acting aspirin, which addresses cardiology emergencies and pain management. The company is also developing formulations for sublingually administered products, such as melatonin sleep-aid product; vitamins D, E, and K; testosterone; and semaglutide product. In addition, it is developing formulations for anti-nausea products, anti-psychotic products, ED drugs, seizure medication, and other classes of drugs through sublingual administration; and caffeine products, such as a formula for a single dose sublingual pre-workout supplement. The company was founded in 2021 and is headquartered in Estero, Florida.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Revenue63,104USD28,353USD4,261USD1,941USD0USD0USD0USD0USD
    Cost Of Revenue50,818USD22,603USD5,261USD1,057USD—0USD—0USD
    Gross Profit-30,086USD5,750USD-1,000USD884USD—0USD—0USD
    Research Development233,482USD296,723USD100,035USD207,899USD352,887USD263,093USD116,356USD7,000USD
    Selling General Administrative970,211USD1,020,457USD1,654,747USD512,993USD395,692USD15,073,548USD2,650,656USD630,772USD
    Selling And Marketing Expenses1,215,025USD334,739USD93,190USD425,489USD51,311USD219,839USD104,344USD16,678USD
    General And Administrative Expenses970,211USD———————
    Total Operating Expenses2,648,136USD1,651,919USD1,848,424USD1,146,381USD799,890USD15,556,480USD2,518,312USD215,256USD
    Operating Income-2,678,222USD-1,646,169USD-1,849,424USD-1,145,497USD-799,890USD-15,556,480USD-2,518,312USD-215,256USD
    Total Other Income Expense Net1,410,080USD-1,576,723USD-2,858,310USD-704,996USD-1,181,403USD-384,848USD-9,448,801USD93,753USD
    Interest Income56,676USD5,009USD———0USD——
    Income Before Tax-1,268,142USD-3,222,892USD-4,707,734USD-1,850,493USD-1,981,293USD-15,941,328USD-11,967,113USD-537,000USD
    Income Tax Expense0USD————-1,013USD-1,013USD1,013USD
    Net Income-1,268,142USD-3,222,892USD-4,707,734USD-1,850,493USD-1,981,293USD-15,941,328USD-11,966,100USD-537,000USD
    Interest Expense—1,595,315USD6,233,393USD1,480,058USD527,893USD289,931USD891,624USD8,496USD
    Net Interest Income—-1,590,306USD-6,233,393USD-1,480,058USD-527,893USD-289,931USD-342,948USD0USD
    Tax Provision—0USD0USD0USD—0USD—1,013USD
    Net Income From Continuing Ops—-3,222,892USD-4,707,734USD-1,850,493USD-1,981,293USD-15,941,328USD-11,966,100USD-243,629USD
    Ebitda—-1,646,169USD-1,849,424USD1,650,774USD-1,453,400USD-15,651,397USD-11,075,489USD-631,000USD
    Ebit——-1,876,059USD-370,435USD-799,890USD-10,009,678USD-11,075,489USD-242,616USD
    Depreciation And Amortization——-2,021,209USD2,021,209USD—-2,630,000USD2,436,791USD—
    Reconciled Depreciation——————0USD0USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Total Revenue6,202USD0USD0USD0USD—
    Cost Of Revenue6,318USD0USD0USD0USD—
    Gross Profit-116USD0USD0USD0USD—
    Research Development923,914USD144,356USD72,050USD175,316USD—
    Selling General Administrative17,637,432USD3,089,000USD1,340,000USD976,345USD27,791USD
    Selling And Marketing Expenses789,829USD126,094USD39,644USD45,483USD—
    Total Operating Expenses19,351,175USD3,089,000USD1,340,000USD976,345USD25,475USD
    Operating Income-19,351,291USD-3,088,671USD-1,340,000USD-976,345USD-25,480USD
    Interest Expense8,531,275USD892,000USD8,966USD0USD—
    Net Interest Income-8,531,275USD-342,948USD5,804,247USD0USD—
    Income Before Tax-24,480,848USD-12,537,000USD4,464,000USD3,340,000USD-25,475USD
    Tax Provision0USD1,013USD481USD626USD—
    Net Income-24,480,848USD-12,537,000USD4,464,000USD3,340,000USD-25,475USD
    Net Income From Continuing Ops-24,480,848USD-12,537,472USD-359,071USD-597,117USD—
    Ebitda-19,351,291USD-11,645,848USD5,804,000USD3,340,238USD-25,480USD
    Total Other Income Expense Net-5,129,557USD-9,448,801USD5,804,000USD4,317,000USD5USD
    Interest Income—548,676USD5,813,213USD——
    Income Tax Expense—1,013USD481USD626USD—
    Ebit—-1,210,871USD4,464,000USD-596,491USD-53,271USD
    Reconciled Depreciation—0USD0USD0USD—
    Depreciation And Amortization——1,340,000USD—27,791USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets13,540,544USD7,117,147USD1,312,166USD2,403,129USD989,422USD1,965,514USD147,989USD6,663,166USD
    Cash And Equivalents12,167,136USD———————
    Total Current Assets13,465,544USD7,117,147USD1,312,166USD2,403,129USD989,422USD1,965,514USD147,989USD61,809USD
    Other Current Assets1,009,958USD890,149USD55,102USD419,421USD783,189USD618,971USD107,853USD-6,564,582USD
    Total Liabilities1,782,723USD———————
    Total Current Liabilities1,686,196USD3,152,432USD7,592,833USD13,860,506USD10,556,922USD8,868,953USD1,688,077USD6,572,881USD
    Other Current Liabilities714,088USD———————
    Total Stockholder Equity11,757,821USD3,868,463USD-6,376,329USD-11,467,278USD-9,616,785USD-6,952,742USD-1,540,088USD90,285USD
    Total Equity Including Noncontrolling Interest11,757,821USD———————
    Inventory288,450USD369,974USD253,160USD35,437USD——0USD—
    Accounts Payable972,108USD857,925USD1,014,377USD1,060,889USD1,351,639USD1,432,025USD310,219USD903,687USD
    Common Stock129USD17USD353USD4,953USD4,953USD4,890USD22,000USD6,602,076USD
    Retained Earnings-31,749,115USD-30,480,973USD-27,258,081USD-22,550,347USD-20,699,854USD-18,718,561USD-2,777,233USD-15,375,643USD
    Total Liab—3,248,684USD7,688,495USD13,870,407USD10,606,207USD8,918,256USD1,688,077USD6,572,881USD
    Other Current Liab—1,795,293USD5,193,678USD11,414,839USD7,374,712USD5,726,368USD111,026USD5,232,910USD
    Capital Stock—18USD353USD4,953USD4,953USD4,890USD22,032USD221,661USD
    Cash—5,857,024USD1,003,904USD1,948,271USD206,233USD1,346,543USD3,633USD6,601,357USD
    Cash And Short Term Investments—5,857,024USD1,003,904USD1,948,271USD206,233USD1,346,543USD3,633USD6,601,357USD
    Net Debt—-5,357,810USD380,874USD-563,493USD1,624,338USD364,017USD1,263,199USD-6,165,073USD
    Short Term Debt—499,214USD1,384,778USD1,384,778USD1,830,571USD1,710,560USD1,266,832USD436,284USD
    Short Long Term Debt—1,499,214USD5,175,254USD8,624,743USD8,473,423USD6,764,182USD1,266,832USD853,113USD
    Short Long Term Debt Total—499,214USD1,384,778USD1,384,778USD1,830,571USD1,710,560USD1,266,832USD436,284USD
    Common Stock Shares Outstanding—156,685shares1,494,956shares1,238,149shares1,233,341shares947,254shares47,635,581shares690,044shares
    Non Current Assets Total—0USD0USD0USD0USD6,668,521USD0USD6,601,357USD
    Non Current Liabilities Total—96,252USD95,662USD9,901USD49,285USD49,303USD0USD0USD
    Net Working Capital—3,964,715USD-6,280,667USD-11,457,377USD-9,567,500USD-6,903,439USD-1,540,088USD-801,588USD
    Unclassified Current Liabilities—-1,499,214USD-5,175,254USD-8,624,743USD-8,473,423USD-6,764,182USD-1,266,832USD—
    Unclassified Equity—34,349,401USD20,881,046USD11,073,163USD11,073,163USD11,756,039USD1,193,113USD8,642,191USD
    Net Receivables—————36,503USD36,503USD25,034USD
    Unclassified Non Current Assets—————6,668,521USD—6,601,357USD
    Non Currrent Assets Other——————-6,668,522USD-5,028,087USD
    Non Current Liabilities Other———————3,852,553USD
    Unclassified Current Assets———————-6,564,582USD
    Unclassified Non Current Liabilities———————-3,852,553USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Total Assets1,312,166USD147,989USD19,982,392USD300,182,005USD293,221USD
    Other Current Assets55,102USD107,853USD70,049USD600,493USD293,221USD
    Total Liab7,688,495USD1,688,077USD403,328USD11,115,823USD293,696USD
    Total Stockholder Equity-6,376,329USD-1,540,088USD19,579,064USD289,066,182USD-475USD
    Other Current Liab5,193,678USD111,026USD238,939USD94,642USD54,827USD
    Common Stock353USD169,989USD19,901,888USD299,004,802USD718USD
    Capital Stock353USD22,032USD221,500USD221,500USD—
    Retained Earnings-27,258,081USD-2,777,233USD-11,287,754USD-9,938,620USD-25,475USD
    Cash1,003,904USD3,633USD11,174USD497,259USD—
    Cash And Short Term Investments1,003,904USD3,633USD11,174USD497,259USD—
    Total Current Assets1,312,166USD147,989USD81,223USD1,097,752USD293,221USD
    Total Current Liabilities7,592,833USD1,688,077USD403,328USD303,323USD293,696USD
    Net Debt380,874USD1,263,199USD12,384USD-497,259USD238,596USD
    Short Term Debt1,384,778USD1,266,832USD12,384USD27,967USD238,596USD
    Short Long Term Debt5,175,254USD1,266,832USD360,636USD27,967USD—
    Short Long Term Debt Total1,384,778USD1,266,832USD12,384USD27,967USD238,596USD
    Inventory253,160USD0USD———
    Accounts Payable1,014,377USD310,219USD152,005USD180,634USD273USD
    Common Stock Shares Outstanding1,494,956shares689,913shares479,478shares898,437shares682,812shares
    Non Current Assets Total0USD6,668,521USD19,901,169USD299,084,253USD293,221USD
    Non Current Liabilities Total95,662USD0USD0USD10,812,500USD—
    Net Working Capital-6,280,667USD-1,540,088USD-487,861USD-128,789USD—
    Unclassified Current Liabilities-5,175,254USD-1,266,832USD———
    Unclassified Equity20,881,046USD1,045,124USD10,743,430USD——
    Net Receivables—36,503USD———
    Non Currrent Assets Other—-6,668,522USD-24,872,176USD298,785,249USD293,221USD
    Unclassified Non Current Assets—6,668,521USD19,901,169USD——
    Accumulated Other Comprehensive Income——0USD——
    Non Current Liabilities Other——3,852,552USD3,852,553USD—
    Unclassified Non Current Liabilities——-3,852,552USD6,959,947USD—
    Current Deferred Revenue———80USD—
    Other Assets————-293,221USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow YTD

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USD
    Stock Based Compensation157,500USD
    Other Non Cash Items1,115,455USD
    Change To Inventory-77,662USD
    Change To Liabilities-56,427USD
    Change In Working Capital-1,044,464USD
    Operating Cash Flow-5,154,196USD
    Financing Cash Flow16,317,428USD
    Change In Cash11,163,232USD
    End Cash Flow12,167,136USD
    SourceDisclosureDeterministicFinal

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
    Net Income-3,222,892USD-4,707,734USD-1,850,821USD-1,981,293USD-15,941,000USD-8,931,094USD-537,019USD-602,258USD
    Depreciation1,583,890USD5,998,239USD2,021,209USD——0USD0USD—
    Stock Based Compensation13,406USD0USD0USD0USD14,131,250USD—0USD0USD
    Other Non Cash Items-4,575USD-262,260,283USD-1,592,558USD260,874,983USD384,520USD8,192,594USD-533,030,659USD38,272USD
    Change To Inventory-116,814USD-253,160USD-35,437USD—0USD———
    Change In Working Capital-1,408,351USD260,041,937USD318,361USD-260,034,000USD-326,298USD1,218,069USD-230,322USD-28,329USD
    Total Cash From Operating Activities-3,038,522USD-927,841USD-1,103,809USD-1,140,310USD-1,751,528USD479,569USD-533,798,000USD-592,315USD
    Capital Expenditures0USD0USD0USD0USD0USD-4USD-5USD-5USD
    Free Cash Flow-3,038,522USD-927,841USD-1,103,809USD-1,140,310USD-1,751,528USD479,569USD25,504USD-592,320USD
    Net Borrowings-1,059,477USD-16,526USD3,753,347USD0USD2,828,610USD—492,477USD—
    Total Cash From Financing Activities7,891,642USD-16,526USD2,845,847USD0USD3,094,438USD-492,477USD492,477,000USD-13,189,008USD
    Issuance Of Capital Stock8,951,119USD0USD-1USD0USD265,828USD0USD0USD28,561USD
    Change In Cash4,853,121USD-944,367USD1,742,038USD-1,140,310USD1,342,910USD-12,908USD-3,063,000USD-27,683,000USD
    Begin Period Cash Flow1,003,904USD1,948,271USD206,233USD1,346,543USD3,633USD16,541USD19,604,000USD47,287,000USD
    End Period Cash Flow5,857,024USD1,003,904USD1,948,271USD206,233USD1,346,543USD3,633USD16,541,000USD19,604,000USD
    Other Cashflows From Financing Activities-173,913USD6,189,587USD2,845,847USD—-265,828USD880,659USD492,502,504USD-1,995,966USD
    Change To Account Receivables—1,027,920USD——-1,027,920USD——10,000USD
    Unclassified Financing Cash Flow—-6,189,587USD-3,752,347USD——-1,115,491USD-14,299,304USD2,588,281USD
    Sale Purchase Of Stock——-1,000USD——-257,645USD13,781,323USD-13,781,323USD
    Investments—————0USD38,258USD—
    Total Cashflows From Investing Activities——————38,258,000USD13,781,323USD
    Other Cashflows From Investing Activities——————52,058,145USD-13,781,323USD
    Unclassified Investing Cash Flow——————-13,838,398USD27,562,651USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USD
    Net Income-24,480,848USD-1,309,872USD4,464,079USD3,340,238USD-28USD
    Depreciation8,019,448USD0USD0USD0USD—
    Stock Based Compensation14,131,250USD0USD———
    Other Non Cash Items-3,126,718USD10,695USD-5,804,247USD-4,316,583USD0USD
    Change To Inventory-253,160USD0USD———
    Change In Working Capital533,380USD1,033,991USD687,061USD-432,441USD-232USD
    Total Cash From Operating Activities-4,923,488USD-265,186USD-653,107USD-1,408,786USD-260USD
    Capital Expenditures0USD0USD-3USD-4USD0USD
    Free Cash Flow-4,923,488USD-265,186USD-653,107USD-1,408,786USD-260USD
    Net Borrowings6,565,431USD0USD———
    Total Cash From Financing Activities5,923,759USD257,645USD-284,760,279USD296,593,545USD260USD
    Issuance Of Capital Stock265,827USD257,645USD0USD1,000,000USD—
    Change In Cash1,000,271USD-7,541USD-497,259USD497,259USD—
    Begin Period Cash Flow3,633USD11,174USD497,259USD185,496USD—
    End Period Cash Flow1,003,904USD3,633USD11,174USD497,259USD185,496USD
    Other Cashflows From Financing Activities-907,499USD11,984,288USD—-298,540USD260USD
    Change To Account Receivables—-36,503USD—400,000USD—
    Investments—0USD-75,902USD-4,895,106USD—
    Total Cashflows From Investing Activities—13,781,323USD284,916,127USD-294,687,500USD—
    Sale Purchase Of Stock—-13,781,323USD-284,916,127USD——
    Other Cashflows From Investing Activities—-13,781,323USD284,916,127USD-289,792,394USD—
    Unclassified Investing Cash Flow—27,562,646USD———
    Unclassified Financing Cash Flow—2,054,680USD—295,892,085USD—
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q1 2026Quarterly · 2026-03-31GeographyCanada480USD0001493152-26-023802
    Q1 2026Quarterly · 2026-03-31GeographyInternational729USD0001493152-26-023802
    Q1 2026Quarterly · 2026-03-31GeographyUnited States27,144USD0001493152-26-023802
    FY 2025Yearly · 2025-12-31GeographyCanada30USD0001493152-26-013682
    FY 2025Yearly · 2025-12-31GeographyUnited Kingdom19USD0001493152-26-013682
    FY 2025Yearly · 2025-12-31GeographyUnited States6,153USD0001493152-26-013682
    Q3 2025Quarterly · 2025-09-30GeographyCanada40USD0001493152-25-022595
    Q3 2025Quarterly · 2025-09-30GeographyUnited States1,901USD0001493152-25-022595

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.